245 related articles for article (PubMed ID: 33374215)
1. Progress and Challenges of Amniotic Fluid Derived Stem Cells in Therapy of Ischemic Heart Disease.
Fang YH; Wang SPH; Chang HY; Yang PJ; Liu PY; Liu YW
Int J Mol Sci; 2020 Dec; 22(1):. PubMed ID: 33374215
[TBL] [Abstract][Full Text] [Related]
2. Efficient Cardiac Differentiation of Human Amniotic Fluid-Derived Stem Cells into Induced Pluripotent Stem Cells and Their Potential Immune Privilege.
Fang YH; Wang SPH; Gao ZH; Wu SN; Chang HY; Yang PJ; Liu PY; Liu YW
Int J Mol Sci; 2020 Mar; 21(7):. PubMed ID: 32235313
[TBL] [Abstract][Full Text] [Related]
3. Expandable human cardiovascular progenitors from stem cells for regenerating mouse heart after myocardial infarction.
Schwach V; Gomes Fernandes M; Maas S; Gerhardt S; Tsonaka R; van der Weerd L; Passier R; Mummery CL; Birket MJ; Salvatori DCF
Cardiovasc Res; 2020 Mar; 116(3):545-553. PubMed ID: 31287499
[TBL] [Abstract][Full Text] [Related]
4. Recent Progress Using Pluripotent Stem Cells for Cardiac Regenerative Therapy.
Ichimura H; Shiba Y
Circ J; 2017 Jun; 81(7):929-935. PubMed ID: 28603177
[TBL] [Abstract][Full Text] [Related]
5. Direct Reprogramming of Human Amniotic Fluid Stem Cells by OCT4 and Application in Repairing of Cerebral Ischemia Damage.
Qin M; Chen R; Li H; Liang H; Xue Q; Li F; Chen Y; Zhang X
Int J Biol Sci; 2016; 12(5):558-68. PubMed ID: 27019637
[TBL] [Abstract][Full Text] [Related]
6. Perspective on human pluripotent stem cell-derived cardiomyocytes in heart disease modeling and repair.
Li Q; Wang J; Wu Q; Cao N; Yang HT
Stem Cells Transl Med; 2020 Oct; 9(10):1121-1128. PubMed ID: 32725800
[TBL] [Abstract][Full Text] [Related]
7. Generation, characterization, and potential therapeutic applications of cardiomyocytes from various stem cells.
Liu J; Zhang Z; Liu Y; Guo C; Gong Y; Yang S; Ma M; Li Z; Gao WQ; He Z
Stem Cells Dev; 2012 Aug; 21(12):2095-110. PubMed ID: 22428725
[TBL] [Abstract][Full Text] [Related]
8. Cryopreservation of Human Pluripotent Stem Cell-Derived Cardiomyocytes: Strategies, Challenges, and Future Directions.
Preininger MK; Singh M; Xu C
Adv Exp Med Biol; 2016; 951():123-135. PubMed ID: 27837559
[TBL] [Abstract][Full Text] [Related]
9. Amniotic fluid-derived stem cells for cardiovascular tissue engineering applications.
Petsche Connell J; Camci-Unal G; Khademhosseini A; Jacot JG
Tissue Eng Part B Rev; 2013 Aug; 19(4):368-79. PubMed ID: 23350771
[TBL] [Abstract][Full Text] [Related]
10. Another possible cell source for cardiac regenerative medicine: reprogramming adult fibroblasts to cardiomyocytes and endothelial progenitor cells.
Xie X; Sun A; Huang Z; Zhu W; Wang S; Zou Y; Ge J
Med Hypotheses; 2011 Mar; 76(3):365-7. PubMed ID: 21087827
[TBL] [Abstract][Full Text] [Related]
11. Myocardial interstitial fluid inhibits proliferation and cardiomyocyte differentiation in pluripotent embryonic stem cells.
Van Orman JR; Weihrauch D; Warltier DC; Lough J
Am J Physiol Heart Circ Physiol; 2009 Oct; 297(4):H1369-76. PubMed ID: 19633209
[TBL] [Abstract][Full Text] [Related]
12. Human amniotic fluid-derived stem cells are rejected after transplantation in the myocardium of normal, ischemic, immuno-suppressed or immuno-deficient rat.
Chiavegato A; Bollini S; Pozzobon M; Callegari A; Gasparotto L; Taiani J; Piccoli M; Lenzini E; Gerosa G; Vendramin I; Cozzi E; Angelini A; Iop L; Zanon GF; Atala A; De Coppi P; Sartore S
J Mol Cell Cardiol; 2007 Apr; 42(4):746-59. PubMed ID: 17300799
[TBL] [Abstract][Full Text] [Related]
13. Xenografted human amniotic fluid-derived stem cell as a cell source in therapeutic angiogenesis.
Liu YW; Roan JN; Wang SP; Hwang SM; Tsai MS; Chen JH; Hsieh PC
Int J Cardiol; 2013 Sep; 168(1):66-75. PubMed ID: 23046594
[TBL] [Abstract][Full Text] [Related]
14. How to repair a broken heart with pluripotent stem cell-derived cardiomyocytes.
Eschenhagen T; Ridders K; Weinberger F
J Mol Cell Cardiol; 2022 Feb; 163():106-117. PubMed ID: 34687723
[TBL] [Abstract][Full Text] [Related]
15. Non-coding RNAs in Cardiac Regeneration.
van der Ven CFT; Hogewoning BCR; van Mil A; Sluijter JPG
Adv Exp Med Biol; 2020; 1229():163-180. PubMed ID: 32285411
[TBL] [Abstract][Full Text] [Related]
16. Stem cells in cardiac repair.
Henning RJ
Future Cardiol; 2011 Jan; 7(1):99-117. PubMed ID: 21174514
[TBL] [Abstract][Full Text] [Related]
17. Regenerative Medicine/Cardiac Cell Therapy: Pluripotent Stem Cells.
Duran AG; Reidell O; Stachelscheid H; Klose K; Gossen M; Falk V; Röll W; Stamm C
Thorac Cardiovasc Surg; 2018 Jan; 66(1):53-62. PubMed ID: 29216651
[TBL] [Abstract][Full Text] [Related]
18. CCND2 Overexpression Enhances the Regenerative Potency of Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes: Remuscularization of Injured Ventricle.
Zhu W; Zhao M; Mattapally S; Chen S; Zhang J
Circ Res; 2018 Jan; 122(1):88-96. PubMed ID: 29018036
[TBL] [Abstract][Full Text] [Related]
19. Stem Cell Technology in Cardiac Regeneration: A Pluripotent Stem Cell Promise.
Duelen R; Sampaolesi M
EBioMedicine; 2017 Feb; 16():30-40. PubMed ID: 28169191
[TBL] [Abstract][Full Text] [Related]
20. Pluripotent Stem Cells for Cardiac Regeneration　- Current Status, Challenges, and Future Perspectives.
Shiba Y
Circ J; 2020 Nov; 84(12):2129-2135. PubMed ID: 33087630
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
